ZADITOR
Company: Ciba Vision
Approval Status: Approved July 1999
Treatment for: Ophthalmology
Areas: Ophthalmology
General Information
Other Useful Resources
ZADITOR (ketotifen fumarate ophthalmic solution) 0.025%, Rx, has been approved for the prevention of itching of the eye due to allergic conjunctivitis.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
